3
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T0078 | Lapatinib | GSK572016,GW572016 | EGFR , Ferroptosis , Autophagy |
Lapatinib (GW572016) is an inhibitor of ErbB2 and EGFR (IC50=9.2/10.8 nM) with oral activity. Lapatinib has antitumor activity and can be used to treat advanced or metastatic breast cancer with HER2 overexpression. | |||
T6235 | Lapatinib Ditosylate | Lapatinib (GW-572016) Ditosylate,GW-572016 ditosylate,Tykerb ditosylate | EGFR , Ferroptosis , Autophagy |
Lapatinib Ditosylate (Tykerb ditosylate) is an effective EGFR and ErbB2 inhibitor (IC50: 10.8/9.2 nM for EGFR/ErbB2). | |||
T72577 | Lapatinib tosylate | GW2016 tosylate,GW572016 tosylate,GW572016 tosylate ; GW2016 tosylate | |
Lapatinib tosylate (GW572016), a robust and orally administered inhibitor specifically targeting the tyrosine kinase domains of ErbB-2 and EGFR, exhibits inhibitory concentration 50 (IC50) values of 10.2 nM and 9.8 nM ag... |